Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -1441.45% is 57% below its 5-year average of -917.82%, around the middle of its 5-year range (-3564.37%–5.87%).
6.42% above its 12-month average of -1540.33%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -723.16%.
EBITDA MARGIN
-1441.45%
EBITDA MARGIN AVG TTM
-1540.33%
EBITDA MARGIN AVG 3Y
-1833.75%
EBITDA MARGIN AVG 5Y
-917.82%
EBITDA MARGIN AVG 10Y
1.88%
EBITDA MARGIN AVG 15Y
6.35%
EBITDA MARGIN AVG 20Y
4.12%
CURRENT VS TTM AVG
+6.42%
CURRENT VS 3Y AVG
+21.39%
CURRENT VS 5Y AVG
-57.05%
CURRENT VS 10Y AVG
-76622.23%
CURRENT VS 15Y AVG
-22794.58%
CURRENT VS 20Y AVG
-35063.20%
CAMP4 Therapeutics Corporation
Market Cap
$240.66M
EBITDA Margin
-1441.45%
TTM Avg
-1540.33%
3Y Avg
-1833.75%
5Y Avg
-917.82%
Market Cap
$240.82M
EBITDA Margin
10.49%
TTM Avg
1.20%
3Y Avg
-4.19%
5Y Avg
-40.04%
Market Cap
$240.09M
EBITDA Margin
-163095.33%
TTM Avg
-97357.05%
3Y Avg
-88166.59%
5Y Avg
-88166.59%
Market Cap
$243.81M
EBITDA Margin
6.37%
TTM Avg
-0.39%
3Y Avg
-2.45%
5Y Avg
1.13%
Market Cap
$243.66M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$244.64M
EBITDA Margin
-100.05%
TTM Avg
-392.29%
3Y Avg
-392.29%
5Y Avg
-392.29%
Market Cap
$236.14M
EBITDA Margin
-43.93%
TTM Avg
-56.69%
3Y Avg
-115.93%
5Y Avg
-139.79%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $240.66M | -1441.45% | -1540.33% | -1833.75% | -917.82% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.82M | 10.49% | 1.20% | -4.19% | -40.04% |
| InflaRx N.V. (IFRX)vs › | $240.09M | -163095.33% | -97357.05% | -88166.59% | -88166.59% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.81M | 6.37% | -0.39% | -2.45% | 1.13% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.66M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $237.25M | 1.66% | 3.74% | -1.53% | 0.81% |
| Galectin Therapeutics Inc. (GALT)vs › | $243.34M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $244.64M | -100.05% | -392.29% | -392.29% | -392.29% |
| MacroGenics, Inc. (MGNX)vs › | $236.14M | -43.93% | -56.69% | -115.93% | -139.79% |
| BioAge Labs Inc. (BIOA)vs › | $235.40M | -1029.09% | -1029.09% | -1029.09% | -1029.09% |
Gross Margin
53.1%
EBITDA Margin
-1441.5%
Operating Margin
-1488.3%
Net Margin
-2543.7%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -723.16% |
| 2026-03-31 | -969.94% |
| 2025-12-31 | -3564.37% |
| 2025-09-30 | -1602.64% |
| 2025-06-30 | -841.55% |
| 2025-03-31 | -1477.74% |
| 2024-12-31 | -2088.34% |
| 2023-08-31 | -3402.29% |
| 2023-05-31 | -2.78% |
| 2023-02-28 | -0.49% |
| 2022-11-30 | 1.74% |
| 2022-08-31 | -6.20% |
| 2022-05-31 | -7.38% |
| 2022-02-28 | -4.97% |
| 2021-11-30 | -0.86% |
| 2021-08-31 | 5.87% |
| 2021-05-31 | 5.34% |
| 2021-02-28 | 1.13% |
| 2020-11-30 | -14.92% |
| 2020-08-31 | 0.80% |
| 2020-05-31 | -3.88% |
| 2020-02-29 | -25.59% |
| 2019-11-30 | 4.50% |
| 2019-08-31 | 4.19% |
| 2019-05-31 | 0.27% |
| 2019-02-28 | 21.71% |
| 2018-11-30 | 6.50% |
| 2018-08-31 | 9.83% |
| 2018-05-31 | 4.44% |
| 2018-02-28 | 5.99% |
| 2017-11-30 | 10.56% |
| 2017-08-31 | 9.80% |
| 2017-05-31 | 5.17% |
| 2017-02-28 | 1.79% |
| 2016-11-30 | 9.18% |
| 2016-08-31 | 11.02% |
| 2016-05-31 | 3.59% |
| 2016-02-29 | 8.75% |
| 2015-11-30 | 15.01% |
| 2015-08-31 | 14.95% |
| 2015-05-31 | 14.49% |
| 2015-02-28 | 16.77% |
| 2014-11-30 | 12.80% |
| 2014-08-31 | 12.18% |
| 2014-05-31 | 11.51% |
| 2014-02-28 | 11.39% |
| 2013-11-30 | 12.57% |
| 2013-08-31 | 11.40% |
| 2013-05-31 | 9.20% |
| 2013-02-28 | 9.05% |
| 2012-11-30 | 11.38% |
| 2012-08-31 | 10.23% |
| 2012-05-31 | 10.98% |
| 2012-02-28 | 5.79% |
| 2011-11-26 | 7.37% |
| 2011-08-27 | 10.77% |
| 2011-05-28 | 4.59% |
| 2011-02-28 | 5.74% |
| 2010-11-27 | 2.52% |
| 2010-08-28 | 0.19% |
| 2010-05-29 | -5.47% |
| 2010-02-28 | -1.06% |
| 2009-11-28 | -5.92% |
| 2009-08-29 | -10.11% |
| 2009-05-30 | -12.44% |
| 2009-02-28 | -184.07% |
| 2008-11-29 | -2.56% |
| 2008-08-30 | -0.08% |
| 2008-05-31 | 5.38% |
| 2008-03-01 | -31.19% |
| 2007-12-01 | -202.58% |
| 2007-09-01 | -7.12% |
| 2007-06-02 | -32.18% |
| 2007-03-03 | 4.14% |
| 2006-11-30 | 5.51% |
| 2006-08-31 | 7.62% |
| 2006-05-31 | -69.53% |
| 2006-02-28 | 14.02% |
| 2005-11-30 | 5.72% |
| 2005-08-31 | 12.69% |
| 2005-05-31 | 9.16% |
| 2005-02-28 | 9.20% |
| 2004-11-30 | 7.02% |
| 2004-08-31 | 7.87% |
| 2004-05-31 | 7.12% |
| 2004-02-28 | 9.63% |
| 2003-11-30 | 10.42% |
| 2003-08-31 | 5.33% |
| 2003-05-31 | -2.82% |
| 2003-03-01 | 8.96% |
| 2002-11-30 | 10.52% |
| 2002-08-31 | 13.80% |
